Pichai Raman
Spark Therapeutics (United States)(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity(2012)8,404 cited
- → Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1(2010)1,954 cited
- → The landscape of genomic alterations across childhood cancers(2018)1,566 cited
- → Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy(2015)1,229 cited
- → Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma(2017)1,211 cited
- → Comprehensive Analysis of Hypermutation in Human Cancer(2017)786 cited
- → Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer(2020)325 cited
- → Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling(2013)319 cited
- → Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape(2020)227 cited
- → Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma(2017)224 cited